ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

NCI Offers Fellowship Training In Epidemiology & Genetics.

February 18, 2000

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014